Combining siRNA and AAV therapy approaches to target human basal-like breast cancer: from vector development to anti-tumor efficacy evaluation.

info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBBB-BIO%2F1240%2F2012/PTCombining siRNA and AAV therapy approaches to target human basal-like breast cancer: from vector development to anti-tumor efficacy evaluation.